Methadone Maintenance Treatment Outcome Study in Taiwan (M0508)
Opioid abuse is a complex problem, which not only impacts on the affected individuals' physical and psychological health, but also threatens public security and the productivity of the society. Further, through needle sharing and sexual contacts, injecting drug users (IDUs) have become laden with HIV and HIV related health problems, representing a serious public health threat all over the world. In Taiwan, since the identification of the first HIV-infected IDU in 1987, the incident cases have continued to increase, reaching a height of 2,461 in 2005. In order to contain the epidemics of HIV among IDUs, and to prevent its spread to the population in general, the Center for Disease Control (CDC) collaborated with the Department of Justice to initiate and implement a number of harm reduction programs in 2005. The fact that opioid addiction is officially treated as a health rather than a legal issue itself represents a remarkable milestone in Taiwan. Among these harm reduction programs, including needle and syringe exchange for IDUs as well as substitution treatment approaches for opioid dependence, methadone maintenance treatment (MMT) perhaps represents the most most important and most crucial component. Remarkably, in a relatively short time span, more than 60 MMT programs were established, which enrolled more than 15,000 heroin addicts. This notwithstanding, the overall and differential effectiveness of these MMT service delivery systems, as well as the characteristics of these programs and the patients that might contribute toward treatment response or failure remain largely unknown. Such knowledge base is crucial for establishing standardized and feasible outcome evaluation processes for opioid addicts receiving MMT programs, as well as for the further improvement of the efficacy and effectiveness of these programs, in Taiwan.
In order to address some of these issues, this study adopts a multi-site, prospective clinical follow-up design. It aims at establishing a research network for examining MMT outcome, developing standardized MMT outcome assessment instruments and procedures, and identifying predictors of MMT outcome. The findings may contribute to the better understanding of the characteristics of opioid addicts, the effectiveness of MMT and remaining service needs for opioid addicts in Taiwan.
Přehled studie
Postavení
Podmínky
Typ studie
Zápis (Očekávaný)
Kontakty a umístění
Studijní místa
-
-
-
Miaoli, Tchaj-wan
- Nábor
- Departments of Psychiatry, Wei-Gong Memorial Hospital
-
Vrchní vyšetřovatel:
- Ming-Lun Liu, MD
-
Kontakt:
- Ming-Lun Liu, MD
-
Taichung, Tchaj-wan
- Nábor
- Departments of Psychiatry, China Medical University and Hospital
-
Vrchní vyšetřovatel:
- Chieh-Liang Huang, MD
-
Kontakt:
- Chieh-Liang Huang, MD
-
Taipei, Tchaj-wan
- Nábor
- Departments of Psychiatry, Taipei City Hospital Song-De Campus
-
Vrchní vyšetřovatel:
- Lien-Wen Su, MD
-
Kontakt:
- Lien-Wen Su, MD
-
Taipei, Tchaj-wan
- Nábor
- Departments of Psychiatry, Taipei City Hospital Yang-Ming Campus
-
Vrchní vyšetřovatel:
- Yih-Hong Yang, MD
-
Dílčí vyšetřovatel:
- Yung-Chun Fang, MD
-
Kontakt:
- Yih-Hong Yang, MD
-
Taipei, Tchaj-wan
- Nábor
- Departments of Psychiatry, Far-Eastern Memorial Hospital
-
Vrchní vyšetřovatel:
- Chi-Shin Wu, MD
-
Dílčí vyšetřovatel:
- Kai-Chi Fang, MD
-
Kontakt:
- Chi-Shin Wu, MD
-
Taipei County, Tchaj-wan
- Nábor
- Departments of Psychiatry, En-Chu-Kong Hospital
-
Vrchní vyšetřovatel:
- Li-Nen Lin, MD
-
Dílčí vyšetřovatel:
- Yen-Feng Lin, MD
-
Kontakt:
- Li-Nen Lin, MD
-
Tao-Yuan, Tchaj-wan
- Nábor
- Departments of Psychiatry, Tao-yuan Psychiatric Center
-
Kontakt:
- Happy Kuy-Lok Tan, MD, MPH
-
Vrchní vyšetřovatel:
- Happy Kuy-Lok Tan, MD, MPH
-
Dílčí vyšetřovatel:
- Sun-Yuan Chou, MD
-
Dílčí vyšetřovatel:
- Kuen-Hong Wu, MD
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
- Be 18 years or older.
- Be fulfilling the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria of opiate dependence.
- Be agree to and capable of signing informed consent form that has been approved by an Institution Review Board.
Exclusion Criteria:
- Have ever participated in the study at one of the collaborative hospitals/clinics.
- Be expecting to discontinue methadone treatment for any reason (leaving the methadone clinic's geographic area, pending legal action, etc.) in the following 3 months.
Studijní plán
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
|---|
|
Heroin-addicted Patients
Heroin-addicted outpatient department (OPD) patients who seek help for methadone maintenance treatment
|
Spolupracovníci a vyšetřovatelé
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Očekávaný)
Dokončení studie (Očekávaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 99A1-PHPP39 (Jiné číslo grantu/financování: National Health Research Institutes)
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .